Abstract:Tumor specific drug delivery has become increasingly interesting in cancer therapy, as the use of chemotherapeutics is often limited due to severe side effects. Conventional drug delivery systems have shown low efficiency and a continuous search for more advanced drug delivery principles is therefore of great importance. In the first part of this review, we present current strategies in the drug delivery field, focusing on site-specific triggered drug release from liposomes in cancerous tissue. Currently marketed drug delivery systems lack the ability to actively release the carried drug and rely on passive diffusion or slow non-specific degradation of the liposomal carrier. To obtain elevated tumor-to-normal tissue drug ratios, it is important to develop drug delivery strategies where the liposomal carriers are actively degraded specifically in the tumor tissue. Many promising strategies have emerged ranging from externally triggered light- and thermosensitive liposomes to receptor targeted, pH- and enzymatically triggered liposomes relying on an endogenous trigger mechanism in the cancerous tissue. However, even though several of these strategies were introduced three decades ago, none of them have yet led to marketed drugs and are still far from achieving this goal. The most advanced and prospective technologies are probably the prodrug strategies where non-toxic drugs are carried and activated specifically in the malignant tissue by overexpressed enzymes. In the second part of this paper, we review our own work, exploiting secretory phospholipase A2 as a site-specific trigger and prodrug activator in cancer therapy. We present novel prodrug lipids together with biophysical investigations of liposome systems, constituted by these new lipids and demonstrate their degradability by secretory phospholipase A2. We furthermore give examples of the biological performance of the enzymatically degradable liposomes as advanced drug delivery systems.

Prodrug Systems (I): Lipid-Based Doxorubicin Prodrugs and Their Nanodelivery Systems

An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin

Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

Transforming a Toxic Drug into an Efficacious Nanomedicine Using a Lipoprodrug Strategy for the Treatment of Patient-Derived Melanoma Xenografts.

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug As Potent Chemotherapeutic Nanomedicine

Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes

A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market

Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: a versatile drug delivery paradigm

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy

Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy

Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy

Structure‐Based Rational Design of Prodrugs to Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy

A Prodrug Nanoassembly Entrapping Drugs As a Tumor-Targeted Delivery System.

Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release

Doxorubicin Conjugated Phospholipid Prodrugs As Smart Nanomedicine Platforms for Cancer Therapy

Advances in cell membrane-based biomimetic nanodelivery systems for natural products

Novel nano-drug delivery system for natural products and their application